Pamicell Signs Supply Contract Worth 5 Billion KRW
[Asia Economy Reporter Hwang Yoon-joo] Pharmicell announced on the 21st that it has signed a supply contract for pharmaceutical intermediate nucleosides worth 4,997.5 million KRW with the US life sciences company Thermo Fisher Scientific. This accounts for 13.24% of recent sales. The supply period is from March 20, 2022, to February 10, 2023.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- 59% of Americans Say "U.S. Prime Has Already Passed"... 44% Pessimistic About Next 50 Years
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
